SP

Subhashini Puligadda

Active Director Director DIN 10940993
DIN 10940993 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhashini Puligadda

Data last updated:

Subhashini Puligadda is a Director at Glovet Life Sciences Private Limited (since 2025). The company operates in Healthcare.

DIN 10940993
Primary Designation Director
Industry Healthcare
First Appointment 06 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glovet Life Sciences Private Limited U47721TS2025PTC193774
Director06 Feb 20252025Active

Board colleagues of Subhashini Puligadda

Directorship timeline

Open interactive timeline →
Glovet Life Sciences Private Limited
Premium access

Shareholding and investment profile for Subhashini Puligadda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhashini Puligadda

Subhashini Puligadda currently holds 1 directorship: Glovet Life Sciences Private Limited (Director, since 06 Feb 2025).

Subhashini Puligadda was first appointed on 06 Feb 2025 as Director at Glovet Life Sciences Private Limited.

The current boards of Subhashini Puligadda's companies include Chandra Sekhar Korrapati (Glovet Life Sciences Private Limited), Satheesh Babu Kotla (Glovet Life Sciences Private Limited), Vijay Kumar Cingeetam (Glovet Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available